Literature DB >> 20029198

High prevalence of peripheral arterial disease in patients with acute ischaemic stroke.

Raffi Topakian1, Sylvia Nanz, Bernhard Rohrbacher, Renate Koppensteiner, Franz T Aichner.   

Abstract

BACKGROUND: After acute ischaemic stroke (AIS) or transient ischaemic attack (TIA), the detection of peripheral arterial disease (PAD) as a marker of generalized atherosclerosis may improve the risk stratification and prevention of future atherothrombotic events. We aimed to determine the prevalence of PAD indicated by an ankle-brachial index (ABI) of < or =0.9 in a large cohort of patients with AIS/TIA.
METHODS: In this prospective, multicentre, Austrian, cross-sectional study (OECROSS), 759 patients with AIS or TIA were recruited for a systematic assessment of cardiovascular risk profiles and Doppler ultrasound at the ankle and brachial artery to calculate the ABI from systolic blood pressure readings.
RESULTS: 739 patients (97.4%) had a complete ABI assessment. The mean age was 69.5 (+/- 12.1) years, and 55.8% of the patients were men. 81.6% of the patients had AIS and 18.4% had TIA. Only 6.2% of the patients had a history of PAD, but an abnormal ABI of < or =0.9 was found in 44.9%. Patients with an ABI of < or =0.9 were more likely (p < 0.05) to be older and have a history of PAD, hypertension, diabetes and congestive heart failure. An ABI of < or =0.9 was significantly associated (p < 0.0005) with a presence of carotid stenosis of >50% and an Essen Stroke Risk Score of >2, indicating a risk of > or =4% per year of stroke recurrence. DISCUSSION: A high proportion of patients with AIS/TIA have subclinical PAD, a cross-risk stroke physicians should be aware of. Large longitudinal studies are needed to elucidate whether the ABI can improve our estimation of the risk of future atherothrombotic events and help in optimizing secondary prevention. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 20029198     DOI: 10.1159/000267850

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  7 in total

1.  Cardiovascular responses to walking in patients with peripheral artery disease.

Authors:  Raphael Mendes Ritti-Dias; Annelise Lins Meneses; Donald E Parker; Polly S Montgomery; Aman Khurana; Andrew W Gardner
Journal:  Med Sci Sports Exerc       Date:  2011-11       Impact factor: 5.411

2.  Cryptogenic mechanism in ischaemic stroke patients is a predictor of 5-year survival: A population-based study.

Authors:  S Timsit; P Bailly; E Nowak; F M Merrien; D Hervé; I Viakhireva-Dovganyuk; A Jourdain; E Thomas; P Goas; F Rouhart
Journal:  Eur Stroke J       Date:  2016-09-10

3.  CHA2DS2-VASc Score and Risk of New-Onset Peripheral Arterial Occlusive Disease in Patients without Atrial Fibrillation.

Authors:  Tzu-Chieh Lin; Ho-Ming Su; Wen-Hsien Lee; Cheng-An Chiu; Nai-Yu Chi; Wei-Chung Tsai; Tsung-Hsien Lin; Wen-Chol Voon; Wen-Ter Lai; Sheng-Hsiung Sheu; Po-Chao Hsu
Journal:  Acta Cardiol Sin       Date:  2021-05       Impact factor: 2.672

Review 4.  Role of endothelin receptor A and NADPH oxidase in vascular abnormalities.

Authors:  De-Zai Dai; Yin Dai
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

5.  The ARTICO study: identification of patients at high risk of vascular recurrence after a first non-cardioembolic stroke.

Authors:  Joaquín Serena; Tomás Segura; Jaume Roquer; María García-Gil; José Castillo
Journal:  BMC Neurol       Date:  2015-03-11       Impact factor: 2.474

6.  Association between modified CHA2DS2-VASc Score with Ankle-Brachial index < 0.9.

Authors:  Po-Chao Hsu; Wen-Hsien Lee; Hsiang-Chun Lee; Wei-Chung Tsai; Chun-Yuan Chu; Ying-Chih Chen; Chee-Siong Lee; Tsung-Hsien Lin; Wen-Chol Voon; Sheng-Hsiung Sheu; Ho-Ming Su
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.379

7.  Prevalence of visceral artery involvement in patients with peripheral artery disease found on run-off MRA.

Authors:  Felix Streckenbach; Felix G Meinel; Felix Ammermann; Anke Busse; Andreas Neumann; Thomas Heller; Marc-André Weber; Ebba Beller
Journal:  BMC Med Imaging       Date:  2021-06-02       Impact factor: 1.930

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.